These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11451675)

  • 1. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Shinzato T; Doyle E; Edelstein MA
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Higa F; Edelstein MA
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH; Shinzato T; Edelstein MA
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Lehr KH; Ren J
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Weiss WJ; Edelstein MA
    Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
    Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Holzknecht B
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
    Edelstein PH; Hu B; Edelstein MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of azithromycin activity against Legionella spp.
    Edelstein PH
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
    Stamler DA; Edelstein MA; Edelstein PH
    Antimicrob Agents Chemother; 1994 Feb; 38(2):217-22. PubMed ID: 8192446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J; St-Pierre C
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
    Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
    J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
    Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
    Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
    García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
    Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
    Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs.
    García-de-Lomas J; Millás E; Lázaro MA; Bermejo M; Gimeno C; Navarro D; Sánchez S
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):420-3. PubMed ID: 9758285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legionella: macrolides or quinolones?
    Pedro-Botet L; Yu VL
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():25-30. PubMed ID: 16669926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.